Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 6 studies | 21% ± 6% | |
epithelial cell | 5 studies | 30% ± 10% | |
ciliated cell | 3 studies | 25% ± 6% | |
endothelial cell | 3 studies | 24% ± 8% | |
GABAergic neuron | 3 studies | 24% ± 1% | |
glutamatergic neuron | 3 studies | 33% ± 2% | |
oligodendrocyte | 3 studies | 17% ± 1% | |
basal cell | 3 studies | 24% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 3956.43 | 21 / 21 | 100% | 22.53 | 504 / 504 |
breast | 100% | 2815.61 | 459 / 459 | 100% | 28.08 | 1118 / 1118 |
ovary | 100% | 2458.37 | 180 / 180 | 100% | 21.16 | 430 / 430 |
prostate | 100% | 4243.00 | 245 / 245 | 100% | 28.68 | 502 / 502 |
uterus | 100% | 3198.38 | 170 / 170 | 100% | 26.39 | 459 / 459 |
esophagus | 100% | 3296.34 | 1443 / 1445 | 100% | 19.69 | 183 / 183 |
brain | 100% | 2944.65 | 2638 / 2642 | 100% | 29.31 | 705 / 705 |
lung | 100% | 2991.64 | 577 / 578 | 100% | 21.86 | 1155 / 1155 |
stomach | 100% | 2177.46 | 358 / 359 | 100% | 19.10 | 286 / 286 |
thymus | 100% | 2448.25 | 652 / 653 | 100% | 22.98 | 603 / 605 |
intestine | 100% | 4017.31 | 966 / 966 | 99% | 19.74 | 523 / 527 |
adrenal gland | 100% | 3784.79 | 258 / 258 | 99% | 15.39 | 227 / 230 |
kidney | 99% | 1723.24 | 88 / 89 | 100% | 18.73 | 898 / 901 |
liver | 98% | 1418.08 | 221 / 226 | 99% | 19.19 | 402 / 406 |
pancreas | 94% | 1126.07 | 308 / 328 | 98% | 21.66 | 175 / 178 |
skin | 100% | 2695.08 | 1804 / 1809 | 90% | 12.13 | 425 / 472 |
blood vessel | 100% | 5430.59 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.24 | 29 / 29 |
spleen | 100% | 1912.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.82 | 1 / 1 |
adipose | 100% | 3127.47 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2221.23 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 2421.05 | 839 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 6.75 | 58 / 80 |
peripheral blood | 22% | 432.09 | 200 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0032993 | Cellular component | protein-DNA complex |
GO_0016602 | Cellular component | CCAAT-binding factor complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NFYB |
Protein name | Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB) Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) |
Synonyms | HAP3 hCG_1811685 |
Description | FUNCTION: Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'-CCAAT-3' box motif found in the promoters of its target genes. NF-Y can function as both an activator and a repressor, depending on its interacting cofactors. FUNCTION: Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'-CCAAT-3' box motif found in the promoters of its target genes. NF-Y can function as both an activator and a repressor, depending on its interacting cofactors. . |
Accessions | ENST00000240055.8 ENST00000551727.5 F8VSL3 P25208 ENST00000551446.6 |